• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性肝癌患者治疗前后血清白细胞介素-2及可溶性白细胞介素-2受体水平变化及其临床意义]

[Changes in serum IL-2 and sIL-2R levels in patients with primary hepatic carcinoma before and after treatment and their clinical significance].

作者信息

Wang M, Feng Y, Zhou X

机构信息

Department of Surgical Oncology, First Affiliated Hospital Zhejiang Medical University, Hangzhou.

出版信息

Zhonghua Zhong Liu Za Zhi. 1995 Jan;17(1):33-5.

PMID:7656784
Abstract

Serum IL-2 and sIL-2R levels were measured with sandwith ELISA assay before and after surgery or transarterial embolization in 19 cases of primary hepatic carcinoma. The results show that pretreatment IL-2 levels of patients were significantly lower and sIL-2R expression was higher than those of normal control. IL-2 levels of patient were increased and sIL-2R expression was decreased after treatment. The results suggest that the changes of IL-2 level and sIL-2R expression may be closely related to treatment, recurrence and prognosis of patients with primary hepatic carcinoma.

摘要

采用夹心ELISA法检测了19例原发性肝癌患者手术或经动脉栓塞前后血清白细胞介素-2(IL-2)和可溶性白细胞介素-2受体(sIL-2R)水平。结果显示,患者治疗前IL-2水平显著低于正常对照组,sIL-2R表达高于正常对照组。治疗后患者IL-2水平升高,sIL-2R表达降低。结果提示,IL-2水平和sIL-2R表达的变化可能与原发性肝癌患者的治疗、复发及预后密切相关。

相似文献

1
[Changes in serum IL-2 and sIL-2R levels in patients with primary hepatic carcinoma before and after treatment and their clinical significance].[原发性肝癌患者治疗前后血清白细胞介素-2及可溶性白细胞介素-2受体水平变化及其临床意义]
Zhonghua Zhong Liu Za Zhi. 1995 Jan;17(1):33-5.
2
[Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].金龙胶囊对原发性肝癌经动脉化疗栓塞治疗后患者白细胞介素-2及可溶性白细胞介素-2受体表达的影响
Zhong Xi Yi Jie He Xue Bao. 2008 Sep;6(9):907-10. doi: 10.3736/jcim20080906.
3
Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.丙型慢性肝病患者血清白细胞介素-10、白细胞介素-12及可溶性白细胞介素-2受体水平
Hepatogastroenterology. 2003 Sep-Oct;50(53):1569-74.
4
[Dynamic studies of NK activity, IL-2 production and sIL-2R expression in primary hepatic carcinoma patients before and after operation].[原发性肝癌患者手术前后自然杀伤细胞活性、白细胞介素-2产生及可溶性白细胞介素-2受体表达的动态研究]
Zhonghua Zhong Liu Za Zhi. 1993 Mar;15(2):111-3.
5
Prognostic value of serum biological markers in patients with hepatocellular carcinoma.血清生物学标志物在肝细胞癌患者中的预后价值。
Clin Cancer Res. 2001 Nov;7(11):3504-9.
6
Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.肺癌患者血清中白细胞介素-18(IL-18)和可溶性白细胞介素-2受体(sIL-2R)的水平
Rocz Akad Med Bialymst. 2004;49:246-51.
7
[Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].[多发性骨髓瘤患者血清白细胞介素2及可溶性白细胞介素2受体的变化及其临床意义]
Zhonghua Zhong Liu Za Zhi. 1996 Nov;18(6):439-41.
8
[The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].[食管癌患者放疗前后可溶性白细胞介素2受体水平]
Zhonghua Zhong Liu Za Zhi. 1995 Mar;17(2):97-9.
9
[Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].[食管癌患者的可溶性白细胞介素2受体(sIL-2R)]
Zhonghua Zhong Liu Za Zhi. 1993 Jan;15(1):17-9.
10
Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study.褪黑素联合经动脉化疗栓塞术治疗晚期原发性肝细胞癌患者的前瞻性研究。
Hepatobiliary Pancreat Dis Int. 2002 May;1(2):183-6.